Upgrade to SI Premium - Free Trial

Amarin Corp. (AMRN)

12.11 -0.62 (4.87%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/29/26 *Est.)

Latest Headlines

Form 10-Q AMARIN CORP PLC\UK For: Sep 30 October 28, 2026 7:06 AM - SEC Filing Form 8-K AMARIN CORP PLC\UK For: Oct 28 October 28, 2026 7:05 AM - SEC Filing Amarin Reports 2026 Third Quarter Financial Results, Achieves Positive Net Income October 28, 2026 7:00 AM - StreetInsider Amarin's Vascepa shows OS benefit in colorectal cancer trial October 25, 2026 8:11 AM - StreetInsider Amarin Provides Update on University of Leeds Sponsored Phase 3 EPA for Metastasis Trial 2 (EMT2) Evaluating VAZKEPA®/VASCEPA® (icosapent ethyl) Capsules on Top of Standard of Care Treatment in Pati October 25, 2026 8:11 AM - Globe NewsWire Amarin to Report Third Quarter 2026 Financial Results and Host Conference Call on October 28, 2026 October 21, 2026 8:00 AM - StreetInsider Amarin presents new REDUCE-IT data at ESC Congress 2026 August 31, 2026 8:15 AM - StreetInsider Amarin Highlights New REDUCE-IT® and Mechanistic Data Presented at European Society of Cardiology (ESC) Congress 2026 August 31, 2026 8:15 AM - StreetInsider Amarin presents REDUCE-IT legacy analysis at ESC Congress 2026 August 28, 2026 8:16 AM - StreetInsider New REDUCE-IT® Legacy Analysis Presented at European Society of Cardiology (ESC) Congress 2026 Suggests Persistent Cardiovascular Benefit Following Icosapent Ethyl Treatment Cessation in Adherent Pat August 28, 2026 8:15 AM - StreetInsider Amarin to present REDUCE-IT analyses at ESC Congress 2026 August 24, 2026 8:17 AM - StreetInsider New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026 August 24, 2026 8:15 AM - StreetInsider JPMorgan Reinstates Amarin Corporation (AMRN) at Underweight August 21, 2026 3:28 AM - StreetInsider Form 4 AMARIN CORP PLC\UK For: Aug 01 Filed by: Fishman Peter L. August 3, 2026 4:31 PM - SEC Filing Full Article List